Clinical insights and therapeutic strategies in Kindler syndrome: a comprehensive review

Mariana G. A. Ares; Valeria B. Inclán

doi:10.18203/issn.2455-4529.IntJResDermatol20242365

Authors

Mariana G. A. Ares Hospital General Regional #1, Instituto Mexicano del Seguro Social, Querétaro, México
Valeria B. Inclán Hospital General Regional #1, Instituto Mexicano del Seguro Social, Querétaro, México

DOI:

https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20242365

Keywords:

Kindler, Syndrome, Skin

Abstract

Kindler syndrome is a rare autosomal recessive genodermatosis characterized by acral blistering in infancy, photosensitivity, progressive poikiloderma, and skin atrophy. This review aims to provide an in-depth analysis of the clinical manifestations, molecular pathogenesis, diagnostic criteria, and therapeutic approaches for Kindler syndrome. We discuss the role of FERMT1 mutations in the disruption of keratinocyte adhesion and migration, contributing to the phenotypic features of the disease. Additionally, we examine the multidisciplinary management strategies encompassing dermatologic, ophthalmologic, and gastrointestinal care, emphasizing the importance of early diagnosis and personalized treatment plans. Emerging therapies and ongoing research into gene therapy and targeted molecular treatments are also explored. This comprehensive review seeks to enhance the understanding of Kindler syndrome among clinicians and researchers, fostering improved patient outcomes through informed clinical practice and innovative therapeutic developments.

Metrics

Metrics Loading ...

References

Kindler T. Congenital poikiloderma with traumatic bulla formation and progressive cutaneous atrophy. Br J Dermatol. 1954;66:104-11.

Fine J-D, Eady RAJ, Bauer EA, Bauer JW, Bruckner-Tuderman L, Heagerty A, et al. The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol. 2008;58:931-50.

Youssefian L, Vahidnezhad H, Uitto J. Kindler Syndrome. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews®. Seattle (WA): University of Washington, Seattle. 2016;1993-2018.

Torres-Iberico R, Palomo-Luck P, Torres-Ramos G, LipaChancolla R. Epidermolysis bullosa in Perú: Clinical and epidemiological study of patients treated in a national reference pediatric hospital, 1993-2015. Rev Peru Med Exp Salud Pública. 2017;34:201-8.

Has C, Castiglia D, del Rio M, Garcia Diez M, Piccinni E, Kiritsi D, et al. Kindler syndrome: Extension of FERMT1 mutational spectrum and natural history. Hum Mutat. 2011;32:1204-12.

Kern J, Herz C, Haan E, Moore D, Nottelmann S, von Lilien T, et al. Chronic colitis due to an epithelial barrier defect: The role of kindlin-1 isoforms. J Pathol. 2007;213:462-70.

Manzur G, Suarez E, Natale M, Valinotto L, Maglio S, Mássimo MP, et al. Síndrome de Kindler: enfermedad rara. Rev Hosp Niños (B. Aires). 2014;56(252):5-10.

Yazdanfar A, Hashemi B. Kindler syndrome: Report of three cases in a family and a brief review. Int J Dermatol. 2009;48:145-9.

Fine J-D, Bruckner-Tuderman L, Eady RAJ, Bauer EA, Bauer JW, Has C, et al. Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classification. J Am Acad Dermatol. 2014;70:1103-26.

Handa N, Kachhawa D, Jain VK, Rao P, Das A. Kindler’s syndrome: A tale of two siblings. Indian J Dermatol. 2016;61:468.

Lai-Cheong JE, Tanaka A, Hawche G, Emanuel P, Maari C, Taskesen M, et al. Kindler syndrome: A focal adhesion genodermatosis. Br J Dermatol. 2009;160(2):233-42.

Rognoni E, Widmaier M, Jakobson M, Ruppert R, Ussar S, Katsougkri D, et al. Kindlin-1 controls Wnt and TGF- availability to regulate cutaneous stem cell proliferation. Nat Med. 2014;20:350-9.

Saleva M, Has C, He Y, Vassileva S, Vassileva S, Balabanova M, Miteva L. Natural history of Kindler syndrome and propensity for skin cancer - case report and literature review. JDDG. 2018;16:338-41.

Barbosa NM, Visioli F, Martins MD, Martins AT, Munerato MC. Oral manifestations in Kindler syndrome: Case report and discussion of literature findings. Spec Care Dentist. 2016;36:223-30.

Lanschuetzer CM, Muss WH, Emberger M, Pohla-Gubo G, Klausegger A, Bauer JW, et al. Characteristic immunohistochemical and ultrastructural findings indicate that Kindler’s syndrome is an apoptotic skin disorder. J Cutan Pathol. 2003;30:553-60.

Shimizu H, Sato M, Ban M, Ishizaki S, Kitajima Y, Ishizaki S, Harada T, et al. Immunohistochemical, ultrastructural, and molecular features of Kindler syndrome distinguish it from dystrophic epidermolysis bullosa. Arch Dermatol. 1997;133:1111-7.

Sanchez-Jimeno C, Escamez MJ, Ayuso C, Trujillo-Tiebas MJ, del Rio M. Genetic diagnosis of epidermolysis bullosa: recommendations from an expert Spanish research group. Actas Dermosifiliogr. 2018;109(2):104-22.

El Fekih N, Mahfoudh A, Zekri S, Kharfi M, Fazaa B, Jaafoura MH, et al. Le syndrome de Kindler, particularités cliniques et ultrastucturales à travers trois nouvelles observations familiales. Ann Pathol. 2011;31:246-50.